R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM Consensus Conference Committee
DOI : 10.1378/chest.101.6.1644

C. Brun-buisson, P. Meshaka, P. Pinton, B. Vallet, and E. Group, EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units, Intensive Care Med, vol.30, issue.4, pp.580-588, 2004.

G. Kumar, N. Kumar, A. Taneja, T. Kaleekal, S. Tarima et al., Nationwide trends of severe sepsis in the 21st century, pp.1223-1254, 2000.

J. Quenot, C. Binquet, F. Kara, O. Martinet, F. Ganster et al., The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study, Critical Care, vol.17, issue.2, p.65, 2013.
DOI : 10.1186/cc12598

URL : https://hal.archives-ouvertes.fr/inserm-00873494

P. Asfar, Y. Claessens, J. Duranteau, E. Kipnis, M. Leone et al., Residual rates of mortality in patients with severe sepsis: a fatality or a new challenge? Ann Intensive Care, p.27, 2013.

D. Angus, W. Linde-zwirble, J. Lidicker, G. Clermont, J. Carcillo et al., Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care, Critical Care Medicine, vol.29, issue.7, pp.291303-291313, 2001.
DOI : 10.1097/00003246-200107000-00002

A. Pavon, C. Binquet, F. Kara, O. Martinet, F. Ganster et al., Profile of the Risk of Death After Septic Shock in the Present Era, Critical Care Medicine, vol.41, issue.11, 2013.
DOI : 10.1097/CCM.0b013e31829a6e89

S. Benchekroune, P. Karpati, C. Berton, C. Nathan, M. J. Chaara et al., Diastolic Arterial Blood Pressure: A Reliable Early Predictor of Survival in Human Septic Shock, The Journal of Trauma: Injury, Infection, and Critical Care, vol.64, issue.5, pp.1188-95, 2008.
DOI : 10.1097/TA.0b013e31811f3a45

D. Dopp-zemel and A. Groeneveld, High-Dose Norepinephrine Treatment: Determinants of Mortality and Futility in Critically Ill Patients, American Journal of Critical Care, vol.22, issue.1, pp.22-32
DOI : 10.4037/ajcc2013748

A. Kumar, D. Roberts, K. Wood, B. Light, J. Parrillo et al., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Critical Care Medicine, vol.34, issue.6, pp.341589-96, 2006.
DOI : 10.1097/01.CCM.0000217961.75225.E9

M. Paul, V. Shani, E. Muchtar, G. Kariv, E. Robenshtok et al., Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis, Antimicrobial Agents and Chemotherapy, vol.54, issue.11
DOI : 10.1128/AAC.00627-10

C. Brun-buisson, F. Doyon, J. Carlet, P. Dellamonica, F. Gouin et al., Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis, JAMA: The Journal of the American Medical Association, vol.274, issue.12, pp.274968-74, 1995.
DOI : 10.1001/jama.274.12.968

V. Ranieri, B. Thompson, P. Barie, J. Dhainaut, I. Douglas et al., Drotrecogin Alfa (Activated) in Adults with Septic Shock, New England Journal of Medicine, vol.366, issue.22, pp.2055-64
DOI : 10.1056/NEJMoa1202290

URL : https://hal.archives-ouvertes.fr/inserm-00865183

S. Opal, P. Laterre, B. Francois, S. Larosa, D. Angus et al., Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis, JAMA, vol.309, issue.11, pp.3091154-62
DOI : 10.1001/jama.2013.2194

C. Martin, X. Viviand, M. Leone, and X. Thirion, Effect of norepinephrine on the outcome of septic shock, Critical Care Medicine, vol.28, issue.8, pp.2758-65, 2000.
DOI : 10.1097/00003246-200008000-00012

F. Weis, E. Kilger, A. Beiras-fernandez, K. Nassau, D. Reuter et al., Association between vasopressor dependence and early outcome in patients after cardiac surgery, Anaesthesia, vol.20, issue.10, pp.61938-61980, 2006.
DOI : 10.1016/S0003-4975(03)01510-8

O. Abid, S. Akca, P. Haji-michael, and J. Vincent, Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure, Critical Care Medicine, vol.28, issue.4, pp.947-956, 2000.
DOI : 10.1097/00003246-200004000-00006

S. Subramanian, M. Yilmaz, A. Rehman, R. Hubmayr, B. Afessa et al., Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study, Intensive Care Medicine, vol.32, issue.1, pp.157-62, 2008.
DOI : 10.1097/00003246-199811000-00016

P. Amrein, C. Colecchi, D. Finkelstein, and R. Fabian, Adjuvant Chemotherapy in Advanced Head and Neck Cancer, Oncologist, vol.2, issue.3, pp.135-176, 1997.

J. Vincent, R. Moreno, J. Takala, S. Willatts, D. Mendonca et al., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis- Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med, issue.7, pp.22707-22717, 1996.

M. Merouani, B. Guignard, F. Vincent, S. Borron, P. Karoubi et al., Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic, Critical Care, vol.12, issue.6, pp.12-155, 2008.
DOI : 10.1186/cc7149

URL : https://hal.archives-ouvertes.fr/inserm-00359832

C. Teixeira, F. Tonietto, T. , C. Goncalves, S. Viegas-cremonese et al., Noradrenaline use is not associated with extubation failure in septic patients, Anaesth Intensive Care, vol.36, issue.3, pp.385-90, 2008.

J. Vincent, D. Bihari, P. Suter, H. Bruining, J. White et al., The prevalence of nosocomial infection in intensive care 43

A. De-boer, J. Mannien, J. Wille, M. Beaumont, and B. Mooi, den Hof S: Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system, Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee, pp.639-44271, 1995.

S. Fridkin, Increasing prevalence of antimicrobial resistance in intensive care units, Critical Care Medicine, vol.29, issue.Supplement
DOI : 10.1097/00003246-200104001-00002

A. Morrice, E. Jackson, and S. Farnell, Practical considerations in the administration of intravenous vasoactive drugs in the critical care setting. Part II--how safe is our practice? Intensive Crit Care Nurs, pp.183-192, 2004.

L. Argaud, M. Cour, O. Martin, M. Saint-denis, T. Ferry et al., Changeovers of vasoactive drug infusion pumps: impact of a quality improvement program Survival after shock requiring high-dose vasopressor therapy, R133. 28. Brown SM, pp.664-71, 2007.

D. Backer, D. Biston, P. Devriendt, J. Madl, C. Chochrad et al., Comparison of Dopamine and Norepinephrine in the Treatment of Shock, New England Journal of Medicine, vol.362, issue.9, pp.779-89, 2010.
DOI : 10.1056/NEJMoa0907118

D. Annane, P. Vignon, R. A. Bollaert, P. Charpentier, C. Martin et al., Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial, The Lancet, vol.370, issue.9588, pp.676-84, 2007.
DOI : 10.1016/S0140-6736(07)61344-0

J. Cohen, The immunopathogenesis of sepsis, Nature, vol.288, issue.6917, pp.885-91, 2002.
DOI : 10.1038/nature01023

S. Santangelo, R. Gamelli, and R. Shankar, Myeloid Commitment Shifts Toward Monocytopoiesis After Thermal Injury and Sepsis, Annals of Surgery, vol.233, issue.1, pp.97-106, 2001.
DOI : 10.1097/00000658-200101000-00015

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1421160/pdf

F. Pinheiro-da-silva and V. Nizet, Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection, Apoptosis, vol.245, issue.4, pp.509-530, 2009.
DOI : 10.4049/jimmunol.174.8.5110

M. Pinsky, Dysregulation of the Immune Response in Severe Sepsis, The American Journal of the Medical Sciences, vol.328, issue.4, pp.220-229, 2004.
DOI : 10.1097/00000441-200410000-00005

N. Ducrocq, A. Kimmoun, A. Furmaniuk, Z. Hekalo, F. Maskali et al., Comparison of equipressor doses of norepinephrine, epinephrine, and phenylephrine on septic myocardial dysfunction, Anesthesiology, vol.2012, issue.1165, pp.1083-91

J. Deng, K. Muthu, R. Gamelli, R. Shankar, and S. Jones, Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis, American Journal of Physiology-Cell Physiology, vol.287, issue.3, pp.730-736, 2004.
DOI : 10.1038/nm0798-808

K. Muthu, J. Deng, R. Gamelli, R. Shankar, and S. Jones, Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis, Journal of Neuroimmunology, vol.158, issue.1-2, pp.50-57, 2005.
DOI : 10.1016/j.jneuroim.2004.08.003

L. Sekut, B. Champion, K. Page, J. Menius, J. Connolly et al., Anti-inflammatory activity of salmeterol: down-regulation of cytokine production, Clinical & Experimental Immunology, vol.152, issue.3, pp.461-467, 1995.
DOI : 10.1056/NEJM198709103171102

K. Hartemink and A. Groeneveld, Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity?, Inflammation, vol.78, issue.1, pp.206-219
DOI : 10.1093/bja/78.5.530

R. Spengler, R. Allen, D. Remick, R. Strieter, and S. Kunkel, Stimulation of alphaadrenergic receptor augments the production of macrophage-derived tumor necrosis factor, J Immunol, vol.145, issue.5, pp.1430-1434, 1990.

A. Severn, N. Rapson, C. Hunter, and F. Liew, Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists, J Immunol, vol.148, issue.11, pp.3441-3446, 1992.

J. Russell, Management of Sepsis, New England Journal of Medicine, vol.355, issue.16, pp.1699-713, 2006.
DOI : 10.1056/NEJMra043632

M. Bahloul, A. Chaari, B. Mbarek, M. Kallel, H. Bouaziz et al., Use of Heptaminol Hydrochloride for Catecholamine Weaning in Septic Shock, American Journal of Therapeutics, vol.19, issue.1, pp.8-17
DOI : 10.1097/MJT.0b013e3181e9b630

A. Levine, M. Meyer, E. Bittner, S. Berg, R. Kalman et al., Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions, Journal of Critical Care, vol.28, issue.5, pp.756-62
DOI : 10.1016/j.jcrc.2013.05.021

O. Donnell, B. Synnott, and A. , Midodrine, an alternative to intravenous vasopressor therapy after spinal surgery, European Journal of Anaesthesiology, vol.19, issue.11, pp.841-843, 2002.
DOI : 10.1017/S0265021502251352

S. Sharma and B. Bhambi, Successful Treatment of Hypotension Associated With Stunned Myocardium with Oral Midodrine Therapy, Journal of Cardiovascular Pharmacology and Therapeutics, vol.38, issue.1, pp.77-86, 2005.
DOI : 10.2165/00003495-198938050-00004

S. Sharma, J. Lardizabal, and B. Bhambi, Oral Midodrine Is Effective for the Treatment of Hypotension Associated With Carotid Artery Stenting, Journal of Cardiovascular Pharmacology and Therapeutics, vol.33, issue.2, pp.94-101, 2008.
DOI : 10.2165/00003495-198938050-00004

D. Cruz, Midodrine: a selective ??-adrenergic agonist for orthostatic hypotension and dialysis hypotension, Expert Opinion on Pharmacotherapy, vol.44, issue.4, pp.835-875, 2000.
DOI : 10.1038/ki.1993.287

D. Mctavish and K. Goa, Midodrine, Drugs, vol.38, issue.5, pp.757-77, 1989.
DOI : 10.2165/00003495-198938050-00004

F. Fouad-tarazi, M. Okabe, and H. Goren, Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension, The American Journal of Medicine, vol.99, issue.6, pp.604-614, 1995.
DOI : 10.1016/S0002-9343(99)80246-0

H. Grobecker and F. Kees, Pharmacokinetic parameters and haemodynamic actions of midodrine in young volunteers, Int Angiol, vol.12, issue.2, pp.119-143, 1993.

R. Hainsworth, Reflexes from the heart., Physiological Reviews, vol.71, issue.3, pp.617-58, 1991.
DOI : 10.1152/physrev.1991.71.3.617

H. Kaufmann, T. Brannan, L. Krakoff, M. Yahr, and J. Mandeli, Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine), Neurology, vol.38, issue.6, pp.951-957, 1988.
DOI : 10.1212/WNL.38.6.951

J. Jankovic, J. Gilden, B. Hiner, H. Kaufmann, D. Brown et al., Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine, The American Journal of Medicine, vol.95, issue.1, pp.38-48, 1993.
DOI : 10.1016/0002-9343(93)90230-M

E. Kersh, S. Kronfield, A. Unger, R. Popper, S. Cantor et al., Autonomic Insufficiency in Uremia as a Cause of Hemodialysis-Induced Hypotension, New England Journal of Medicine, vol.290, issue.12, pp.650-653, 1974.
DOI : 10.1056/NEJM197403212901203

S. Bergman, Hemodialysis in Hypotensive Heart Failure Using Midodrine, The American Journal of the Medical Sciences, vol.338, issue.6, pp.470-473, 2009.
DOI : 10.1097/MAJ.0b013e3181b7efa7

J. Fernandez-seara, J. Prieto, J. Quiroga, J. Zozaya, M. Cobos et al., Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure, Gastroenterology, vol.97, issue.5, pp.971304-971316, 1989.
DOI : 10.1016/0016-5085(89)91704-6

A. Maroto, P. Gines, V. Arroyo, A. Gines, J. Salo et al., Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction, Hepatology, vol.17, issue.5, pp.788-93, 1993.

J. Laragh, P. Cannon, C. Bentzel, A. Sicinski, and J. Meltzer, ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES*, Journal of Clinical Investigation, vol.42, issue.7, pp.421179-92, 1963.
DOI : 10.1172/JCI104803

R. Schrier, V. Arroyo, M. Bernardi, M. Epstein, J. Henriksen et al., Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis, Hepatology, vol.116, issue.5, pp.1151-1158, 1988.
DOI : 10.7326/0003-4819-94-2-198

P. Angeli, R. Volpin, D. Piovan, A. Bortoluzzi, R. Craighero et al., Acute effects of the oral administration of midodrine, an ?-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites, Hepatology, vol.26, issue.4, pp.937-980, 1998.
DOI : 10.1002/hep.510280407

K. Werling and N. Chalasani, What is the Role of Midodrine in Patients with Decompensated Cirrhosis?, Gastroenterol Hepatol, vol.7, issue.2, pp.134-140, 2011.

V. Singh, S. Dhungana, B. Singh, R. Vijayverghia, C. Nain et al., Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study, J Hepatol, vol.2012, issue.562, pp.348-54

P. Godin and T. Buchman, Uncoupling of biological oscillators, Critical Care Medicine, vol.24, issue.7, pp.1107-1123, 1996.
DOI : 10.1097/00003246-199607000-00008

H. Schmidt, K. Werdan, and U. Muller-werdan, Autonomic dysfunction in the ICU patient, Current Opinion in Critical Care, vol.7, issue.5, pp.314-336, 2001.
DOI : 10.1097/00075198-200110000-00002

H. Schmidt, U. Muller-werdan, S. Nuding, T. Hoffmann, D. Francis et al., Impaired chemoreflex sensitivity in adult patients with multiple organ dysfunction syndrome?the potential role of disease severity, Intensive Care Medicine, vol.30, issue.4, pp.665-72, 2004.
DOI : 10.1007/s00134-003-2131-2

A. Seely and N. Christou, Multiple organ dysfunction syndrome: Exploring the paradigm of complex nonlinear systems, Critical Care Medicine, vol.28, issue.7, pp.2193-200, 2000.
DOI : 10.1097/00003246-200007000-00003

H. Schmidt, U. Muller-werdan, T. Hoffmann, D. Francis, M. Piepoli et al., Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups*, Critical Care Medicine, vol.33, issue.9, pp.1994-2002, 2005.
DOI : 10.1097/01.CCM.0000178181.91250.99

R. Dellinger, M. Levy, J. Carlet, J. Bion, M. Parker et al., Surviving Sepsis Campaign, Critical Care Medicine, vol.41, issue.2, pp.17-60, 2008.
DOI : 10.1097/CCM.0b013e31827e83af

L. Gall, J. Lemeshow, S. Saulnier, and F. , A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-63, 1993.
DOI : 10.1001/jama.1993.03510240069035

D. Annane, P. Aegerter, M. Jars-guincestre, B. Guidet, and C. Network, Current Epidemiology of Septic Shock, American Journal of Respiratory and Critical Care Medicine, vol.168, issue.2, pp.165-72, 2003.
DOI : 10.1001/jama.1996.03540110043030

D. Backer, D. Biston, P. Devriendt, J. Madl, C. Chochrad et al., Comparison of Dopamine and Norepinephrine in the Treatment of Shock, New England Journal of Medicine, vol.362, issue.9, pp.779-89, 2010.
DOI : 10.1056/NEJMoa0907118

B. Pourrias, Heptaminol chlorhydrate: new data, Ann Pharm Fr, vol.49, issue.3, pp.127-165, 1991.

A. Groeneveld, Risk factors for increased mortality from hospital-acquired versus community-acquired infections in??febrile medical patients, American Journal of Infection Control, vol.37, issue.1, pp.35-42, 2009.
DOI : 10.1016/j.ajic.2007.11.011

T. Kelly, Kinetics of intradialytic disequilibria: the problem, the causes, and new methods for the alleviation of patient morbidity, Nephrology Dialysis Transplantation, vol.11, issue.supp8, p.11, 1996.
DOI : 10.1093/ndt/11.supp8.3

P. Gines and R. Schrier, Renal Failure in Cirrhosis, New England Journal of Medicine, vol.361, issue.13, pp.1279-90, 2009.
DOI : 10.1056/NEJMra0809139